U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240805) titled 'Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies' on Nov. 11.
Brief Summary: Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that ...